Detalhe da pesquisa
1.
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial [version 2; peer review: 2 approved].
NIHR Open Res
; 2: 49, 2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035713
2.
Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis.
BMJ Open
; 13(8): e071906, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562935
3.
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial.
Lancet Rheumatol
; 3(5): e337-e346, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33928262
4.
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial.
Medicine (Baltimore)
; 99(26): e20458, 2020 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32590730
5.
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol.
BMJ Open
; 9(12): e034708, 2019 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857319